title: HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice.
abstract: We have constructed a replication competent, gamma(1)34.5-deleted herpes simplex virus type-1 (HSV-1) vector (J200) that expresses the gag gene from human immunodeficiency virus type-1, primary isolate 89.6 (HIV-1(89.6)), as a candidate vaccine for HIV-1. J200 replicates in vitro, resulting in abundant Gag protein production and accumulation in the extracellular media. Immunization of Balb/c mice with a single intraperitoneal injection of J200 elicited strong Gag-specific CD8 responses, as measured by intracellular IFN-gamma staining and flow cytometry analysis. Responses were highest between 6 weeks and 4 months, but persisted at 9 months post-immunization, the last time-point evaluated. These data highlight the potential utility of neuroattenuated, replication competent HSV-1 vectors for delivery of HIV-1 immunogens.
authors: Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, United States.
authors: Scott D
authors: SD
authors: Parker
authors: Scott T
authors: ST
authors: Rottinghaus
authors: Allan J
authors: AJ
authors: Zajac
authors: Ling
authors: L
authors: Yue
authors: Eric
authors: E
authors: Hunter
authors: Richard J
authors: RJ
authors: Whitley
authors: Jacqueline N
authors: JN
authors: Parker
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002460:Cell Line; D002522:Chlorocebus aethiops; D005260:Female; D015967:Gene Expression Regulation, Viral; D015683:Gene Products, gag / Q000235:genetics / Q000276:immunology* / Q000378:metabolism*; D005822:Genetic Vectors / Q000235:genetics*; D015497:HIV-1 / Q000502:physiology*; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D014779:Virus Replication
chemical_list: D015683:Gene Products, gag
references: Gene Ther. 1998 Jun;5(6):809-19
references: 9747461
references: Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4512-7
references: 10200293
references: J Virol. 1999 Nov;73(11):9145-52
references: 10516021
references: Gene Ther. 1999 Oct;6(10):1751-8
references: 10516725
references: J Virol. 2004 Dec;78(24):13455-9
references: 15564456
references: Sex Transm Dis. 2004 Dec;31(12):753-60
references: 15608591
references: J Virol. 2005 Feb;79(4):2124-32
references: 15681415
references: J Infect Dis. 2005 Mar 1;191(5):654-65
references: 15688278
references: J Infect Dis. 2005 Mar 1;191(5):666-77
references: 15688279
references: J Virol. 2005 Mar;79(6):3243-53
references: 15731219
references: J Virol. 2005 Jun;79(11):7135-45
references: 15890953
references: J Infect Dis. 2001 May 1;183(9):1343-52
references: 11294665
references: J Virol. 2001 Sep;75(18):8724-32
references: 11507217
references: J Virol. 2001 Dec;75(23):11821-6
references: 11689663
references: Expert Opin Biol Ther. 2001 Mar;1(2):177-91
references: 11727528
references: J Immunol. 2002 Jan 1;168(1):332-7
references: 11751978
references: Nature. 2002 Jan 17;415(6869):331-5
references: 11797011
references: AIDS. 2001;15 Suppl 5:S147-58
references: 11816163
references: Annu Rev Immunol. 2002;20:73-99
references: 11861598
references: J Virol. 2002 Apr;76(8):3678-87
references: 11907207
references: J Biomed Sci. 2002 Mar-Apr;9(2):100-11
references: 11914576
references: Gene Ther. 2002 Mar;9(6):398-406
references: 11960316
references: J Virol. 2002 Jun;76(11):5565-80
references: 11991985
references: J Virol. 2003 Jun;77(11):6305-13
references: 12743287
references: J Virol. 2004 Mar;78(5):2212-21
references: 14963117
references: J Virol. 2004 Apr;78(7):3333-42
references: 15016855
references: Gene Ther. 2000 May;7(10):859-66
references: 10845724
references: Gene Ther. 2000 May;7(10):867-74
references: 10845725
references: J Virol. 2000 Sep;74(17):7745-54
references: 10933680
references: J Virol. 2001 May;75(9):4430-4
references: 11287595
references: Science. 2001 Apr 6;292(5514):69-74
references: 11393868
references: J Clin Invest. 1993 Jun;91(6):2837-43
references: 8390490
references: Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60
references: 8108397
references: J Virol. 1994 Jul;68(7):4650-5
references: 8207839
references: J Virol. 1994 Sep;68(9):6103-10
references: 8057491
references: J Gen Virol. 1995 Feb;76 ( Pt 2):321-32
references: 7844554
references: J Virol. 1995 Jun;69(6):3615-23
references: 7745709
references: Science. 1998 Mar 27;279(5359):2103-6
references: 9516110
references: Gene Ther. 1998 Jan;5(1):121-30
references: 9536273
references: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8216-21
references: 9653167
references: J Virol. 1998 Oct;72(10):8264-72
references: 9733870
references: J Gen Virol. 2004 Apr;85(Pt 4):911-9
references: 15039533
references: J Virol. 2004 Apr;78(8):3930-40
references: 15047809
references: J Exp Med. 2004 Jun 21;199(12):1709-18
references: 15210746
references: J Clin Invest. 2004 Aug;114(4):450-62
references: 15314679
references: Gene Ther. 2004 Nov;11(22):1648-58
references: 15334111
references: Cell. 1981 Jul;25(1):227-32
references: 6268303
references: Proc Natl Acad Sci U S A. 1984 Sep;81(18):5867-70
references: 6091116
references: J Virol. 1986 Aug;59(2):494-9
references: 3016310
references: Mol Cell Biol. 1985 Dec;5(12):3403-9
references: 3939316
references: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5200-4
references: 2455898
references: Nature. 1990 Jun 14;345(6276):622-5
references: 2190095
references: Science. 1990 Nov 30;250(4985):1262-6
references: 2173860
references: Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):542-6
references: 1988952
references: Science. 1991 May 10;252(5007):854-6
references: 1851332
references: J Virol. 1992 Jul;66(7):4464-9
references: 1602554
references: Curr Drug Targets Infect Disord. 2005 Jun;5(2):81-3
references: 15975014
references: J Gen Virol. 2005 Sep;86(Pt 9):2401-10
references: 16099897
references: J Infect Dis. 2005 Oct 1;192(7):1249-59
references: 16136469
references: Virology. 2005 Oct 25;341(2):190-202
references: 16098555
references: Vaccine. 2006 Jan 23;24(4):417-25
references: 16176847
references: J Immunol. 2006 May 15;176(10):6130-46
references: 16670322
references: Vaccine. 2006 May 22;24(21):4498-502
references: 16185790
references: Virology. 2007 Jan 20;357(2):199-214
references: 16962628
references: Virology. 2007 Jan 20;357(2):186-98
references: 16996101
references: Vaccine. 2007 Feb 19;25(9):1634-46
references: 17145123
references: J Virol. 1992 Dec;66(12):7517-21
references: 1433527
references: Cancer Gene Ther. 2000 Jan;7(1):118-27
references: 10678364
references: Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2208-13
references: 10681459